One hypothetical scenario is that transformed myeloid-biased HSCs, expressing CD41 but no other lineage markers, produce several subclones, one of which is dominant at a relatively early phase of MDS, and later, a high-grade clone, which is phenotypically close to the transformed HSC, becomes dominant. Here, ITGA2B is linked to myelodysplastic syndrome.